Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2022.454 | A Randomised, Placebo-Controlled, 3-Arm, Double-Blind, Multicentre, Phase 4 Study to Assess the Efficacy of OM-85 (Broncho-Vaxom) Short- and Long-Term Treatment versus Placebo in the Prevention of Respiratory Tract Infections in Children Aged 6-12 Years with Asthma |
Prof. WONG Gary Wing Kin 黃永堅教授 |
| 2015.094 | Comparative study of viral respiratory infections and asthma exacerbations in rural and urban environments | Prof WONG Gary Wing Kin |
| 2024.123 | Molecular Assessment of Thoracic Empyema in Asian children and adolescents (MATE-Asia) – a prospective observational study for improving diagnosis of pneumonia and determining the prevalence of vaccine-preventable pneumococcal empyema |
Prof. WONG Gary Wing Kin 黃永堅 |
| 2018.103 | A20 pathway and immune protection against allergies in a rural environment |
Prof. WONG Gary Wing Kin 黃永堅 |
| 2020.021 | Immune protection against asthma in a rural environment |
Prof. WONG Gary Wing Kin 黃永堅 |
| 2016.095 | Microbiome and atopic disorders in rural China |
Dr. WONG Gary WK 黃永堅 |
| 2017.345 | Prediction of treatment complications in patients with unruptured intracranial aneurysms undergoing preventive aneurysms treatment |
Prof. WONG George Kwok Chu 黃國柱 |
| 2014.171 | Delayed cerebral infarction in aneurysmal subarachnoid hemorrhage: a miRNA study | Prof. WONG George Kwok Chu |
| 2015.153 | Rivastigmine for cognitive impairment after aneurysmal subarachnoid hemorrhage: a randomized placebo-controlled clinical trial. | Prof. WONG George Kwok Chu |
| 2014.333 | Point prevalence observational study in neurosurgery patient requiring high dependency unit to intensive care unit admission | Professor Wong George Kwok Chu |
| 2015.645 | Primary Ventriculoperitoneal Shunting Outcomes: A Multicenter Clinical Audit for Shunt Infection and its Risk Factors |
Prof. WONG George Kwok Chu 黃國柱 |
| 2015.401 | Investigation of neuroprotective effects of umbilical cord-derived mesenchymal stem cells against focal cerebral ischemia in rats |
Prof. WONG George Kwok Chu 黃國柱 |
| 2016.639 | Circulating-microRNA-based classifier of early brain injury after intracranial aneurysm rupture |
Prof. WONG George Kwok Chu 黃國柱 |
| 2015.571 | Outcome of cerebrospinal fluid diversion procedures in Hong Kong - a prospective observational cohort study |
Prof. WONG George Kwok Chu 黃國柱 |
| 2011.124 | Spot sign and contrast extravasation in traumatic intracranial hemorrhage for prediction of hematoma enlargement or neurological deterioration | Prof. Wong George Kwok Chu |
| 2009.075 | Cognitive Dysfunction after Aneurysmal Subarachnoid Haemorrhage: A Post-ISAT Perspective | Prof. WONG George Kwok Chu |
| 2009.178 | High-dose Simvastatin for aneurysmal subarachonid haemorrhage: Is it better? | Prof. WONG George Kwok Chu |
| 2011.123 | Use of the Montreal Cognitive Assessment vs the Mini-Mental State Examination to screen for cognitive impairment in Chinese anaeurysmal subarachoid hemorrhage patients | Prof. WONG George Kwok Chu |
| 2009.301 | Cerebral glucose metabolism after acute aneurysmal subarachnoid haemorrhage | Prof. Wong George Kwok Chu |
| 2011.097 | Cognitive dysfunction and delayed cerebral infarction in Chinese aneurysmal subarachnoid hemorrhage patients | Prof. WONG George Kwok Chu |
| 2020.202 | Development and Validation of a Clinical Risk Score Model for Intracranial Aneurysm Screening in Ischemic Stroke Patients |
Prof. WONG George Kwok Chu 黃國柱 |
| 2020.204 | Establishment and characterization of meningioma patient-derived organoids |
Prof. WONG George Kwok Chu 黃國柱 |
| 2018.291 | Assessment of the Impact of Ultra-Early Aneurysm Treatment on Outcomes in Patients with Poor Neurological Status after Intracranial Aneurysm Rupture |
Prof. WONG George Kwok Chu 黃國柱 |
| 2014.157 | Selective Serotonin Reuptake Inhibitor to improve cognitive function after aneurysmal subarachnoid hemorrhage | Prof. WONG George Kwok Chu |
| 2022.291 | Adjunctive embolization for chronic subdural hematoma at high risk of recurrence: A Phase I RCT (Embo-Subdu I) | Prof. WONG George Kwok Chu |
| 2020.627 | Intracranial aneurysms in ischemic stroke patients: a retrospective review |
Prof. WONG George Kwok Chu 黃國柱 |
| 2023.035 | Machine-learning Method for Retinal Image Analysis to Detect Intracranial Aneurysms | Prof. WONG George Kwok Chu |
| 2021.288 | Prospective Audit of Intracranial Aneurysm Stent Treatment | Prof. WONG George Kwok Chu |
| 2022.116 | Long term outcome of aneurysms treated with flow diverters: multi-center retrospective study | Prof. WONG George Kwok Chu |
| 2021.390 | Impact of Ultra-Early Aneurysm Treatment on outcomes in Patients with Poor Neurological Status after Intracranial Aneurysm Rupture: a retrospective review |
Prof. WONG George Kwok Chu 黃國柱 |
| 2022.666 | Mobile application development for impact assessment of patients after subarachnoid haemorrhage | Prof. WONG George Kwok Chu |
| 2010.075 | Prediction of Delayed Cerebral Ischemia after Aneurysmal Subarachnoid Haemorrhage using Transient Hyperemic Response Test and Implications on Length of Hospitalization | Prof. Wong George Kwok-chu |
| 2007.436 | Co-Operative Study on Brain Injury Depolarisations (COSBID): (Traumatic and Ischaemic Injury to the Human Brain) | Dr. Wong George Kwok-chu |
| 2008.076 | Disability in Young People and Adults One Year after Head Injury: Impact, Causes and Factors | Dr. Wong George Kwok-chu |
| 2008.073 | Computed Tomography Antiography and Venography in Place of Catheter Angiography for Acute Spontaneous Non-Hypertensive Intracerebral Haemorrhage | Dr. Wong George Kwok-chu |
| 2024.460 | A Phase 2b, multi-centre, randomized, partially placebo-controlled, double-blind study to investigate the safety and efficacy of sequential therapy with daplusiran/tomligisiran followed by bepirovirsen in participants with chronic hepatitis B virus on background nucleos(t)ide analogue therapy (B-United) | Prof. WONG Grace |
| 2025.597 | Construction of diagnostic and predictive models for cirrhosis patients with complications of liver disease | Prof. Wong Grace |
| 2024.007 | Secular trend of chronic liver diseases - a retrospective observational cohort study | Prof. WONG Grace |
| 2023.312 | An Open-Label Phase 1b Study Evaluating the Safety, Tolerability, Immunogenicity and Antiviral Activity of Multiple Doses of CLB-3000 in Subjects with Chronic Hepatitis B | Prof. WONG Grace |
| 2021.291 | The setting up of Geriatric Diabetes Programme in a regional hospital of Hong Kong | Dr. WONG Grace Hiu Yan |
| 2020.615 | Evaluation of AFP, AFP-L3, PIVKA-II and GALAD Score (Gender, Age, AFP-L3, AFP, DCP/PIVKA-II) for risk assessment of Hepatocellular Carcinoma (HCC) | Prof. WONG Grace Lai Hung |
| 2022.653 | A Phase 1/2a, Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of BJT-778 in Healthy Volunteers and in Subjects with Chronic Hepatitis B Infection, Including Subjects with Chronic Hepatitis D Infection | Prof. WONG Grace Lai Hung |
| 2021.239 | Retrospective cohort study for early detection of new-onset chronic diseases in recovered COVID-19 patients using population-based datasets | Prof. WONG Grace Lai Hung |
| 2023.265 | A Phase 1a/1b Study to Evaluate the Safety and Tolerability of Repeated Doses of Nonreplicating Arenavirus Vector Therapeutic Vaccines GS-2829 and GS-6779 in Healthy Participants and Participants With Chronic Hepatitis B (CHB) |
Prof. WONG Grace Lai Hung Lai Hung Wong |
| 2020.459 | Elimination of chronic hepatitis B in Hong Kong – to meet the WHO goals |
Prof. WONG Grace Lai Hung 黃麗虹 |
| 2023.151 | A phase 2b, open-label study to evaluate the efficacy, safety, tolerability, immunogenicity and treatment regimens of VTP-300 combined with low-dose nivolumab in Chronic Hepatitis B Infection |
Prof. WONG Grace Lai Hung Grace LH Wong |
| 2021.223 | Drug-Drug Interactions in Patients Treated with DAAs in Hong Kong | Prof. WONG Grace Lai Hung |
| 2022.601 | Real-World Data to Assess HCV Patients Treated with SOF/VEL without RBV |
Prof. Wong Grace Lai Hung 黃麗虹教授 |
| 2022.552 | Phase 3 Multicenter, Randomized, Double-Blind, Study to Assess the Efficacy and Safety of Treatment with Bepirovirsen in Nucleos(t)ide Analogue-treated Participants with Chronic Hepatitis B Virus (B-Well 1) |
Prof. WONG Grace Lai Hung 黃麗虹 |
| 2021.427 | A Phase 2a, Open-Label Study to Evaluate the Safety and Efficacy of Selgantolimod (SLGN)-Containing Combination Therapies for the Treatment of Chronic Hepatitis B (CHB) |
Prof. WONG Grace Lai Hung 黃麗虹教授 |
Page 248 of 289.